Home > Analytics > BAL PHARMA

BAL PHARMA
Intrinsic Value | Fundamental Analysis

BOM : 524824     NSE : BALPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive]
Debt : High
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Neutral
Price Momentum : Downward
Pledged Shares : NA
Dec 06,2024
Price(EOD): ₹ 124.40
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Pharmaceuticals & Drugs
MCap: ₹ 197.80 Cr
Value of ₹ 1 Lac invested in BAL PHARMA
on Dec 06,2019 (price: ₹ 40.10)

₹ 1 L

₹ 3.10 L

1W : -0% 1M : -0.6% 1Y : 16.3%
COMMUNITY POLL
for BAL PHARMA
Please provide your vote to see the results
Industry Peers & Returns1W1M1Y
BAL PHARMA -0% -0.6% 16.3%
SUN PHARMACEUTICAL INDUSTRIES -0.2% 0.1% 47%
CIPLA -2% -7.7% 23.2%
DR REDDYS LABORATORIES 2.6% -1.5% 7.9%
ZYDUS LIFESCIENCES 2.1% 0.6% 54.5%
DIVIS LABORATORIES -1.9% 5.5% 60.6%
MANKIND PHARMA -1.2% -4.8% 36.6%
TORRENT PHARMACEUTICALS -0.2% 4.6% 57.8%
LUPIN 3.1% -2.2% 68.7%

FUNDAMENTAL ANALYSIS OF BAL PHARMA

 
Fundamentals Score
[ Q(TTM): Sep2024, Y: Mar2024
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF BAL PHARMA

 
Valuation Score
[As on : Dec 06,2024 ]

Ratio Consolidated
P/E
P/B
P/S
25.8
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 7.68 Cr
[Latest Qtr - Sep2024 - Consolidated Results ]

2.86
P/B Calculated based on Book Value of Rs 69.29 Cr
[Latest Year - Mar2024 - Consolidated Results ]

0.61
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 324.34 Cr
[Latest Qtr - Sep2024 - Consolidated Results ]

Financial Ratios →

Insights 💡 There are potential 8% undervalued companies ! Discover More →

FAIR VALUE OF BAL PHARMA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
99%
17%
35%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF BAL PHARMA



BAL PHARMA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF BAL PHARMA

Year Debt/Equity ratio
Standalone Consolidated
2024
2023
2022
Avg_3yrs
1.28
1.32
1.15
1.25
2.01
2.05
1.8
1.95
[Last Annual Data : Mar2024]
Financial Ratios →

PLEDGED PROMOTER SHARES OF BAL PHARMA

Pledged Promoter Shares
NA

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF BAL PHARMA

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
-0.89%
19.03%
120.26%
301.16%
-20.37%
-0.04%
-15.06%
7.11%
QtrlyTrend
0
Latest Qtr: Sep2024
Quarterly Result Analysis →


BAL PHARMA related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about BAL PHARMA


Is BAL PHARMA good for long term investment?

As on Dec 06,2024, the Fundamentals of BAL PHARMA look Poor and hence it may not be good for long term investment ! See Financial Performance of BAL PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is BAL PHARMA UnderValued or OverValued?

As on Dec 06,2024, BAL PHARMA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of BAL PHARMA ?

As on Dec 06,2024, the Intrinsic Value of BAL PHARMA is Rs. 92.20 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 62.44
Fair Value [Median EV / Sales Model] : Rs. 106.23
Fair Value [Median Price / Sales Model] : Rs. 92.20
Estimated Median Fair Value of BAL PHARMA : Rs. 92.20

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is BAL PHARMA trading at a Premium or Discount?

As on Dec 06,2024, BAL PHARMA is trading at a Premium of 35% based on the estimates of Median Intrinsic Value!